Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
Incyte’s Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints
Biospace News
-
January 28, 2020
Dermatology
Incyte’s cream formulation of ruxolitinib hits main goal of late-stage atopic dermatitis study
Firstwordpharma News
-
January 28, 2020
Dermatology
Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients...
Firstwordpharma News
-
December 19, 2019
0
Dermatology
LEO Pharma’s experimental drug tralokinumab hits main goals of three pivotal...
Firstwordpharma News
-
December 11, 2019
0
Dermatology
XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for...
Biospace News
-
November 19, 2019
0
Dermatology
Lilly Presents Positive Results for Taltz (ixekizumab) in Pediatric Patients with...
Firstwordpharma News
-
October 13, 2019
0
Dermatology
Pfizer Presents Positive Phase 3 Data at the 28th Congress of...
Firstwordpharma News
-
October 13, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
LATEST NEWS
Marathon-running molecule could speed up the race for new neurological treatments
Firstwordpharma News
-
July 12, 2019
0
Sensorion Announces the Positive Data Safety Monitoring Board (DSMB) Review and Continuation of the Phase 2 Clinical Trial for SENS-111 in Acute Unilateral Vestibulopathy...
May 15, 2019
miRagen Reports Third Quarter 2019 Results and Provides Corporate Update
November 7, 2019
MUST READ
Novartis Eyes Late 2019 Launch for Wet AMD Drug
Biospace News
-
April 16, 2019
0
Novartis Buys IFM Tre in Deal That Could Hit $1.6 Billion
Biospace News
-
April 1, 2019
0
WHO prequalifies first biosimilar medicine to increase worldwide access to life-saving breast cancer treatment
Firstwordpharma News
-
December 18, 2019
0
Load more
